Study to Evaluate the Safety and Efficacy of Seasonale for Treatment of Low Bone Mineral Density
Study Details
Study Description
Brief Summary
This is a randomized, multicenter, placebo-controlled study to evaluate the effects of Seasonale, an extended-regimen oral contraceptive, on bone mineral density in adolescent females who have had their menstrual period but now have secondary amenorrhea and also have osteopenia. The duration of the study for each patient will be approximately two years.
Condition or Disease | Intervention/Treatment | Phase |
---|---|---|
|
Phase 3 |
Study Design
Outcome Measures
Primary Outcome Measures
- Mean percent change in the lumbar spine bone mineral density at month 12 []
Secondary Outcome Measures
- Interim and 24 month mean percent change in lumbar spine bone mineral density []
- Mean percent change in the proximal femur (hip) bone mineral density []
- Mean percent change in total body bone mineral density []
- Mean change in biochemical markers of bone resorption and bone formation []
- Change in body weight []
Eligibility Criteria
Criteria
Inclusion Criteria:
-
Not sexually active and agree to remain sexually inactive throughout the course of the study
-
First menstrual period at least one year ago
-
No menstrual period in the last 6 months
Exclusion Criteria:
-
Undiagnosed abnormal genital bleeding
-
Known or suspected pregnancy
-
Medical history of any disorder that contraindicates the use of oral contraceptives
Contacts and Locations
Locations
No locations specified.Sponsors and Collaborators
- Duramed Research
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- SEA-305